Résumé
Supplementary Material 2: Table S1. Concentration of FST and FSTL3 in Ascites samples from patients and their clinical characteristics.
- Titre
- Additional file 2 of FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer
- Créateurs - sans rôle
- Maeva Chauvin - Massachusetts General HospitalEstelle Tromelin - Massachusetts General HospitalJulien Roche-Prellezo - University of MontpellierHyshem H. Lancia - Massachusetts General HospitalMarie-Charlotte Meinsohn - Massachusetts General HospitalCaroline Coletti - Massachusetts General HospitalNgoc Minh Phuong Nguyen - Massachusetts General HospitalVirginie Lafont - University of MontpellierHenri-Alexandre Michaud - University of MontpellierRanjan Mishra - Whitehead Institute for Biomedical ResearchNathalie Bonnefoy - University of MontpellierLaurent Gros - University of MontpellierDavid Pépin - Massachusetts General Hospital
- Éditeur
- figshare
- Identifiants
- 99162687809311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Dataset